We’ve put our money where our mouth is, says Cann Group as focus turns to generating revenue by Steve Jones November 11, 2022November 11, 2022 The lack of high-quality cannabis around the world is opening up significant commercial opportunities for Cann […]
Cann Group looks to raise another A$10m for Mildura, puts Southern facility up for sale by Martin Lane October 25, 2022October 27, 2022
Company news: Cann Group; Cronos; Releaf Group; Rua Bioscience; Incannex by Martin Lane October 12, 2022October 12, 2022
Company news: Bod Australia; Cann Group; MediCann Health; MGC Pharma; Wellnex Life by Steve Jones and Martin Lane October 5, 2022August 14, 2023
‘Being a start-up in a start-up industry is not easy. It’s been turbulent. But we’re ready to go.’ by Steve Jones August 29, 2022August 31, 2022
Cann Group secures additional funding from NAB, lights up Mildura night sky by Martin Lane July 21, 2022July 21, 2022
When it comes to lobbying, three into one government doesn’t go by Martin Lane July 21, 2022July 21, 2022
Company news: Cann Group; Medlab; ANTG; Medleaf; Ora Pharm; Creso Pharma; Greenfern Industries by Martin Lane June 30, 2022June 30, 2022